Ofloxacin, a fluorinated carboxyquinolone, was tested against 485 clinical isolates, and the MICs and disk inhibitory zones were correlated. A critical zone of .19 mm and an MIC of .2 ,ug/ml indicate susceptibility. An MIC of 4 p.g/ml and a zone size of 16 to 18 mm is intermediate, and an MIC of-8 ,Ig/ml with a zone size of <15 mm indicates resistance. Alternatively, organisms inhibited by an MIC of <4 ,ug/ml with a critical zone diameter of .15 mm could be considered susceptible. By either of these criteria, major errors in judging susceptibility or resistance are <1%.
Ofloxacin is a new carboxy fluorinated quinolone with excellent in vitro activity against many clinically important bacteria. The majority of gram-negative aerobic bacteria are inhibited by s1 jig of ofloxacin per ml (1, 6, 7, 9) . After oral doses of 200 and 400 mg, mean peak concentrations in serum of 2 to 0.5. Each organism had identical MICs each time it was tested, except S. aureus, for which the MIC was 0.25 ,ug/ml 50% of the time and 0.5 p.g/ml 50% of the time. The inhibitory zone diameters correlated well for each control strain (Table 1) .
Ofloxacin showed excellent activity against the majority of the bacteria (Table 2) . Excluding Pseudomonas species, S. faecalis, Providencia species, and Acinetobacter species, the MIC for 90% of strains tested was .0.5 pug/ml. Overall, 90.7 and 81.2% of the total strains had MICs of .1.0 and .0.5 jig/ml, respectively.
Zone diameters ranged from 11 to 46 mm for the 5-,ug disks and from 10 to 44 mm for the 3-p.g disks. Scattergrams for the 3-and 5-,ug disks were similar. The correlation coefficient for both 3-and 5-,ug disks was 0.87, and slopes were -0.327 and -0.285, respectively. The y intercepts were at 67 pg for the 5-R,g disk and at 132 p.g for the 3-,ug disk. The data for the 5-ig disk are shown in Fig. 1 
DISCUSSION
The foregoing evaluation was based on the assumption that microorganisms inhibited by 2.0 ,ug of ofloxacin per ml would be responsive to oral therapy. Peak levels in serum of 2.0 ,ug/ml have followed the oral administration of 200 mg of ofloxacin, and levels of 4 to 6 jig/ml have been achieved after doses of 400 mg. Lockley et al. (2) recorded a mean maximump concentration of 10.7 ,ug/ml at 1.2 h, with levels of 2.3 ,ug/ml present at 8 h after an oral dose of 600 mg. Levels in urine after a dose of 600 mg have been 141 ,ug/ml in the 0-to 4-h period and 6.7 ,ug/ml in the 12-to 24-h period. Current clinical studies of ofloxacin in the United States are being conducted with doses of 500 mg orally every 12 h.
Ofloxacin can select resistant subpopulations of bacteria when microorganisms are exposed to subinhibitory concentrations (1) . it would be reasonable on the basis of the levels in serum to consider strains requiring for inhibition MICs of ofloxacin of <2.0 glg/nl as susceptible and strains requiring MICs of -8 Vig/ml as resistant. This is a conservative estimate which would provide a measure of safety with use of the drug. Alternatively, it probably is reasonable to expect that isolates that require MICs of 4 pg/ml for inhibition would respond to therapy, and only isolates that require MICs of .8 jig/ml for inhibition and that produce tissue infections would not respond to therapy with 500 mg of ofloxacin administered orally twice daily. The high concentrations of ofloxacin in urine which will be achieved suggest that even isolates which would be considered resistant by these definitions may be responsive.
The number of resistant strains tested in this study is small. Many of the isolates in this study were resistant to beta-lactam antibiotics and aminoglycosides, but it was not possible to find a population of resistant organisms without including a disproportionate number of species that are infrequently encountered in clinical infections. However, including more of these strains would not have appreciably improved the reliability of the disk test.
We believe that a 5-p.g disk is more appropriate for the test than a 3-,ug disk in view of the allowable variation in disk content. With ciprofloxacin, a 5-,ug disk is currently used, and with enoxacin, a 10-p.g disk is used. A 3-,ug disk allows for a better predictive value when staphylococci or enteric bacilli are tested, but the difference between the 3-and 5-p.g disks is minor.
